News
Watson Pharmaceuticals gets US approval to buy Actavis but only with conditions set out by the Federal Trade Commission. Watson Pharmaceuticals has won US antitrust approval to buy Swiss firm Actavis Inc but only on the condition is sells the rights…
Cinven announced today that it is to purchase Amdipharm. Cinven, a private equity group, announced today that it is to buy Amdipharm for 367 million pounds. Amdipharm is a family-owned niche…
Watson Laboratories receives FDA approval for generic versions of Sanofi’s Avapro and Allergan’s Sanctura XR. Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has received FDA approval for two generic drugs…
Genzyme has announced positive phase 3 data for its multiple sclerosis drug, Aubagio, following its recent launch. Genzyme, a subsidiary of Sanofi, has announced key data from its phase 3 clinical trials of its multiple sclerosis…
Phase 3 clinical trials results of Pfizer’s investigational chronic pain drug have been announced. Pfizer has announced results from a phase 3 clinical study of its investigational agent ALO-02 in patients with…
Roche and Lilly’s Alzheimer’s drugs have been selected to be tested in a global clinical study by the Washington University, USA. Three experimental Alzheimer’s drugs have been chosen for a worldwide clinical study hosted by the…
Ahead of his speech today, GSK CEO Sir Andrew Witty, pledges to make the company’s clinical trials data more open in order to help tackle worldwide healthcare problems. GSK is to further advance its commitment towards transparency, openness and collaboration, as these…
Perrigo has received FDA approval to market its over-the-counter nicotine lozenge to reduce withdrawal symptoms in adults who are trying to quit smoking. The US FDA has approved Perrigo’s Abbreviated New Drug Applications to market its over-the-counter nicotine…
Pfizer finally settles a shareholder lawsuit that alleged the company was misrepresenting clinical trials data of its arthritis drug, Celebrex. Pfizer has agreed to settle a shareholder class action, accusing the global drug maker of misrepresenting the…
